Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Single-center, Dose-escalation Clinical Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of Tumor Neoantigen-pulsed Autologous Dendritic Cell Injection (YS247) in Study Participants With HRD-negative Epithelial Ovarian Cancer

Peking University Third Hospital · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
naovarian-cancer
hrd-negative epithelial ovarian cancer, tumor neoantigen, autologous dentritic cell, ovarian cancer, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 862362
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.